Does SELUMETINIB Cause Off label use? 78 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Off label use have been filed in association with SELUMETINIB (KOSELUGO). This represents 6.7% of all adverse event reports for SELUMETINIB.
78
Reports of Off label use with SELUMETINIB
6.7%
of all SELUMETINIB reports
4
Deaths
6
Hospitalizations
How Dangerous Is Off label use From SELUMETINIB?
Of the 78 reports, 4 (5.1%) resulted in death, 6 (7.7%) required hospitalization, and 3 (3.8%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELUMETINIB. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does SELUMETINIB Cause?
Blood creatine phosphokinase increased (105)
Rash (89)
Paronychia (73)
Dermatitis acneiform (61)
Diarrhoea (59)
Fatigue (54)
Acne (52)
Nausea (49)
Death (47)
Alopecia (45)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which SELUMETINIB Alternatives Have Lower Off label use Risk?
SELUMETINIB vs SEMAGLUTIDE
SELUMETINIB vs SEMUSTINE
SELUMETINIB vs SENNA LEAF
SELUMETINIB vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SELUMETINIB vs SENNOSIDES